Vanda Pharmaceuticals
VNDA
#7805
Rank
A$0.51 B
Marketcap
A$8.64
Share price
-0.32%
Change (1 day)
29.34%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -A$0.19 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are A$0.21 Billion. In 2024 the company made an earning of -A$56.77 Million a decrease over its 2023 earnings that were of -A$19.48 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.19 Billion231.41%
2024 -A$56.77 Million191.43%
2023 -A$19.48 Million-320.45%
2022 A$8.83 M-84.99%
2021 A$58.86 M54.8%
2020 A$38.02 M19.42%
2019 A$31.84 M4.93%
2018 A$30.34 M-228.6%
2017 -A$23.6 Million-8.98%
2016 -A$25.93 Million-53.79%
2015 -A$56.1 Million-30.18%
2014 -A$80.35 Million173.08%
2013 -A$29.43 Million-25.33%
2012 -A$39.41 Million163.61%
2011 -A$14.95 Million-221.15%
2010 A$12.33 M-124.53%
2009 -A$50.31 Million-29.44%
2008 -A$71.29 Million-36.2%
2007 -A$0.12 Billion21.81%
2006 -A$91.73 Million170.55%
2005 -A$33.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.26 B-21,553.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.03 B-13,134.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.78 B-8,846.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$43.45 B-25,803.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.36 B-10,960.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.39 B-8,025.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-A$3.92 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA